Powder Electrode Separators for High Temperature Lithium‐Aluminum/Iron Sulfide Batteries von Mathers, J. P., Boquist, C. W., Olszanski, T. W.

Volltext

Evaluation of Porous Paper and Felt Ceramics for Electrode Separators in High Temperature Li ‐ Al / LiCl ‐ KCl / FeS x Cells von Mathers, J. P., Olszanski, T. W., Battles, J. E.

Volltext

Evaluation of porous paper and felt ceramics for electrode separators in high temperature Li-Al/LiCl-KCl/FeS sub x cells von Mathers, James P, Olszanski, T W, Battles, J E

Volltext

Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma von Rasco, Drew W., Medina, Theresa, Corrie, Pippa, Pavlick, Anna C., Middleton, Mark R., Lorigan, Paul, Hebert, Chris, Plummer, Ruth, Larkin, James, Agarwala, Sanjiv S., Daud, Adil I., Qiu, Jiaheng, Bozon, Viviana, Kneissl, Michelle, Barry, Elly, Olszanski, Anthony J.

Volltext

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105 von Drilon, Alexander, Fu, Siqing, Patel, Manish R, Fakih, Marwan, Wang, Ding, Olszanski, Anthony J, Morgensztern, Daniel, Liu, Stephen V, Cho, Byoung Chul, Bazhenova, Lyudmila, Rodriguez, Cristina P, Doebele, Robert C, Wozniak, Antoinette, Reckamp, Karen L, Seery, Tara, Nikolinakos, Petros, Hu, Zheyi, Oliver, Jennifer W, Trone, Denise, McArthur, Katherine, Patel, Rupal, Multani, Pratik S, Ahn, Myung-Ju

Volltext

First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors von Papadopoulos, Kyriakos P, Gluck, Larry, Martin, Lainie P, Olszanski, Anthony J, Tolcher, Anthony W, Ngarmchamnanrith, Gataree, Rasmussen, Erik, Amore, Benny M, Nagorsen, Dirk, Hill, John S, Stephenson, Jr, Joe

Volltext

Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors von RINI, Brian I, SCHILLER, Joan H, KIM, Sinil, RIXE, Olivier, FRUEHAUF, John P, COHEN, Ezra E. W, TARAZI, Jamal C, ROSBROOK, Brad, BAIR, Angel H, RICART, Alejandro D, OLSZANSKI, Anthony J, LETRENT, Kristen J

Volltext

Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment von Wagner, Jessica, Kline, C Leah, Zhou, Lanlan, Campbell, Kerry S, MacFarlane, Alexander W, Olszanski, Anthony J, Cai, Kathy Q, Hensley, Harvey H, Ross, Eric A, Ralff, Marie D, Zloza, Andrew, Chesson, Charles B, Newman, Jenna H, Kaufman, Howard, Bertino, Joseph, Stein, Mark, El-Deiry, Wafik S

Volltext

1077TiP TAK-500 as a single agent and in combination with pembrolizumab in patients (pts) with advanced solid tumors: Rationale and design of a phase I/II study von Singh, H., Diamond, J.R., Henry, J.T., Olszanski, A.J., Rasco, D., Patel, S.P., Gregory, R., Appleman, V.A., Gibbs, J.P., Zhang, W., Wang, C.I., Parent, A.A., Chung, V.

Volltext

Treatment of late bacterial infections resulting from soft-tissue filler injections von Marusza, Wojciech, Olszanski, Romuald, Sierdzinski, Janusz, Ostrowski, Tomasz, Szyller, Kamila, Mlynarczyk, Grazyna, Netsvyetayeva, Irina

Volltext

The impact of lifestyle upon the probability of late bacterial infection after soft-tissue filler augmentation von Marusza, Wojciech, Olszanski, Romuald, Sierdzinski, Janusz, Szyller, Kamila, Ostrowski, Tomasz, Gruber-Miazga, Joanna, Netsvyetayeva, Irina

Volltext

Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer von Infante, Jeffrey R., Patnaik, Amita, Verschraegen, Claire F., Olszanski, Anthony J., Shaheen, Montaser, Burris, Howard A., Tolcher, Anthony W., Papadopoulos, Kyriakos P., Beeram, Muralidhar, Hynes, Scott M., Leohr, Jennifer, Lin, Aimee Bence, Li, Lily Q., McGlothlin, Anna, Farrington, Daphne L., Westin, Eric H., Cohen, Roger B.

Volltext

Safety of dual checkpoint-blockade with PSB205, an anti-PD-1/CTLA4 monoclonal antibody combination, manufactured and dispensed as a single product: A phase 1 study von Chugh, Rashmi, Wang, Judy S., Olszanski, Anthony J., Wilky, Breelyn A., Algate, Paul, Plato, Leah, Spira, Alexander I., Korchin, Borys, Kylstra, Jelle W.

Volltext

A phase 1/1b study of RXDX-105, an oral RET and BRAF inhibitor, in patients with advanced solid tumors von Drilon, A, Marwan, F, Fu, S, Patel, M.R, Olszanski, A.J, Lockhart, A.C, Liu, S.V, Bazhenova, L, Seery, T, Nikolinakos, P, Patel, R, Oliver, J.W, Multani, P.S, Wang, D

Volltext

Probable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16 von Marusza, Wojciech, Mlynarczyk, Grazyna, Olszanski, Romuald, Netsvyetayeva, Irina, Obrowski, Michael, Iannitti, Tommaso, Palmieri, Beniamino

Volltext

1006P Phase I dose escalation study of HFB200603, a best-in-class BTLA antagonist monoclonal antibody (mAb), in monotherapy and in combination with the anti-PD-1 mAb tislelizumab (... von De Miguel, M., Landa Magdalena, A., Moreno Garcia, V., Gambardella, V., Menis, J., Daniele, G., El-Khoueiry, A.B., Spira, A.I., Gravina, A., Olszanski, A.J., Rapaic, O., Li, J., Poullain, H., Margall, G., Wong, G., Hedrich, W., Russella Pollard, J., Gan, J., Shi, X., Andtbacka, R.H.I.

Volltext

Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47) von SLINGLUFF, Craig L, PETRONI, Gina R, GROSH, William W, WEISS, Geoffrey R, WAGENSELLER, Aubrey G, OLSZANSKI, Anthony J, MARTIN, Lainie, SHEA, Sofia M, ERDAG, Gulsun, RAM, Prahlad, GERSHENWALD, Jeffrey E, WEBER, Michael J, MOLHOEK, Kerrington R, BRAUTIGAN, David L, CHIANESE-BULLOCK, Kimberly A, SHADA, Amber L, SMOLKIN, Mark E, OLSON, Walter C, GAUCHER, Alison, MURPHY CHASE, Cheryl

Volltext

Navtemadlin (KRT-232) activity after failure of anti-PD-1/L1 therapy in patients (pts) with TP53 WT Merkel cell carcinoma (MCC) von Wong, Michael K.K., Burgess, Melissa Amber, Chandra, Sunandana, Schadendorf, Dirk, Silk, Ann W., Olszanski, Anthony J., Grob, Jean-Jacques, Jang, Sekwon, Grewal, Jaspreet Singh, Lewis, Karl D., Fecher, Leslie Anne, Rabinowits, Guilherme, Lebbe, Celeste, Shen, Annalise, Chan, Tiffanie, McGreivy, Jesse S., Rothbaum, Wayne P., Hanna, Glenn J., Kelly, Ciara Marie

Volltext

A phase 1b, multicenter, dose-escalation study of subasumstat (TAK-981) in combination with pembrolizumab in patients (pts) with advanced solid tumors von Goel, Sanjay, Ulahannan, Susanna Varkey, Olszanski, Anthony J., LoRusso, Patricia, Sanborn, Rachel E., Sharma, Sunil, Emens, Leisha A., Reilley, Matthew, Priego, Victor, Li, Shuli, Wang, Bingxia, Dong, Lixian, Sachsenmeier, Kris, Gibbs, John, Gharavi, Robert, Martinez, Alonzo, Proscurshim, Igor, Fram, Robert J., Gomez-Pinillos, Alejandro, Rasco, Drew W.

Volltext

Skin bacterial flora as a potential risk factor predisposing to late bacterial infection after cross-linked hyaluronic acid gel augmentation von Netsvyetayeva, Irina, Marusza, Wojciech, Olszanski, Romuald, Szyller, Kamila, Krolak-Ulinska, Aneta, Swoboda-Kopec, Ewa, Sierdzinski, Janusz, Szymonski, Zachary, Mlynarczyk, Grazyna

Volltext